Literature DB >> 22584052

Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene.

Makoto Saito1, Yukiko Kato, Emi Ito, Jiro Fujimoto, Kosuke Ishikawa, Ayano Doi, Kentaro Kumazawa, Atsuka Matsui, Shiori Takebe, Takaomi Ishida, Sakura Azuma, Hiromi Mochizuki, Yoshifumi Kawamura, Yuka Yanagisawa, Reiko Honma, Jun-ichi Imai, Hirokazu Ohbayashi, Naoki Goshima, Kentaro Semba, Shinya Watanabe.   

Abstract

Gene amplification is a major genetic alteration in human cancers. Amplicons, amplified genomic regions, are believed to contain "driver" genes responsible for tumorigenesis. However, the significance of co-amplified genes has not been extensively studied. We have established an integrated analysis system of amplicons using retrovirus-mediated gene transfer coupled with a human full-length cDNA set. Applying this system to 17q12-21 amplicon observed in breast cancer, we identified GRB7 as a context-dependent oncogene, which modulates the ERBB2 signaling pathway through enhanced phosphorylation of ERBB2 and Akt. Our work provides an insight into the biological significance of gene amplification in human cancers.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584052     DOI: 10.1016/j.febslet.2012.05.003

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.

Authors:  Ahmed Basudan; Nolan Priedigkeit; Ryan J Hartmaier; Ethan S Sokol; Amir Bahreini; Rebecca J Watters; Michelle M Boisen; Rohit Bhargava; Kurt R Weiss; Maria M Karsten; Carsten Denkert; Jens-Uwe Blohmer; Jose P Leone; Ronald L Hamilton; Adam M Brufsky; Esther Elishaev; Peter C Lucas; Adrian V Lee; Steffi Oesterreich
Journal:  Mol Cancer Res       Date:  2018-10-24       Impact factor: 5.852

2.  CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling.

Authors:  Hee-Joo Choi; Sora Jin; Hani Cho; Hee-Young Won; Hee Woon An; Ga-Young Jeong; Young-Un Park; Hyung-Yong Kim; Mi Kyung Park; Taekwon Son; Kyueng-Whan Min; Ki-Seok Jang; Young-Ha Oh; Jeong-Yeon Lee; Gu Kong
Journal:  EMBO Rep       Date:  2019-08-30       Impact factor: 8.807

3.  Grb7 protein RA domain oligomerization.

Authors:  Malika P Godamudunage; Albert Foster; Darius Warren; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2017-03-14       Impact factor: 2.137

4.  Integration and Analysis of CPTAC Proteomics Data in the Context of Cancer Genomics in the cBioPortal.

Authors:  Pamela Wu; Zachary J Heins; James T Muller; Lizabeth Katsnelson; Ino de Bruijn; Adam A Abeshouse; Nikolaus Schultz; David Fenyö; Jianjiong Gao
Journal:  Mol Cell Proteomics       Date:  2019-07-15       Impact factor: 5.911

5.  An in vivo screening system to identify tumorigenic genes.

Authors:  T Ihara; Y Hosokawa; K Kumazawa; K Ishikawa; J Fujimoto; M Yamamoto; T Muramkami; N Goshima; E Ito; S Watanabe; K Semba
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

6.  Enhanced expression of retinoic acid receptor alpha (RARA) induces epithelial-to-mesenchymal transition and disruption of mammary acinar structures.

Authors:  Ayano Doi; Kosuke Ishikawa; Nao Shibata; Emi Ito; Jiro Fujimoto; Mizuki Yamamoto; Hatsuki Shiga; Hiromi Mochizuki; Yoshifumi Kawamura; Naoki Goshima; Kentaro Semba; Shinya Watanabe
Journal:  Mol Oncol       Date:  2014-09-22       Impact factor: 6.603

7.  Multiplex Ligation-dependent Probe Amplification Can Clarify HER2 Status in Gastric Cancers with "Polysomy 17".

Authors:  Tao Wang; Yutaka Amemiya; Pauline Henry; Arun Seth; Wedad Hanna; Eugene T Hsieh
Journal:  J Cancer       Date:  2015-02-26       Impact factor: 4.207

8.  Methylation-associated silencing of miR-193a-3p promotes ovarian cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.

Authors:  Kangmei Chen; Michelle Xin Liu; Celia Sze-Ling Mak; Mingo Ming-Ho Yung; Thomas Ho-Yin Leung; Dakang Xu; Siew-Fei Ngu; Karen Kar-Loen Chan; Huijuan Yang; Hextan Yuen-Sheung Ngan; David Wai Chan
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

9.  A method of producing genetically manipulated mouse mammary gland.

Authors:  Hiroaki Tagaya; Kosuke Ishikawa; Yoshito Hosokawa; Shun Kobayashi; Yukino Ueoka; Mayuna Shimada; Yasuko Ohashi; Hirofumi Mikami; Mizuki Yamamoto; Tatsuya Ihara; Kentaro Kumazawa; Kosuke Sugihara; Naoki Goshima; Shinya Watanabe; Kentaro Semba
Journal:  Breast Cancer Res       Date:  2019-01-05       Impact factor: 6.466

10.  Identification of druggable cancer driver genes amplified across TCGA datasets.

Authors:  Ying Chen; Jeremy McGee; Xianming Chen; Thompson N Doman; Xueqian Gong; Youyan Zhang; Nicole Hamm; Xiwen Ma; Richard E Higgs; Shripad V Bhagwat; Sean Buchanan; Sheng-Bin Peng; Kirk A Staschke; Vipin Yadav; Yong Yue; Hosein Kouros-Mehr
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.